Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0K0VO
|
||||
| Former ID |
DNC001490
|
||||
| Drug Name |
Urapidil
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Hypertension [ICD9: 401; ICD10:I10-I16] | Approved | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C20H29N5O3
|
||||
| Canonical SMILES |
CN1C(=CC(=O)N(C1=O)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC
|
||||
| InChI |
1S/C20H29N5O3/c1-22-18(15-19(26)23(2)20(22)27)21-9-6-10-24-11-13-25(14-12-24)16-7-4-5-8-17(16)28-3/h4-5,7-8,15,21H,6,9-14H2,1-3H3
|
||||
| InChIKey |
ICMGLRUYEQNHPF-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 115787-68-3
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
455193, 5416504, 7848396, 8153468, 11111935, 11111936, 11114211, 11341954, 11362137, 11364254, 11366816, 11369378, 11372633, 11374064, 11377540, 11466933, 11468053, 11484919, 11486685, 11487539, 11488988, 11491372, 11492048, 11495174, 12014605, 14902854, 26612398, 26680529, 26747180, 26747181, 26752246, 29224676, 47216940, 47216941, 47216942, 47515487, 47810932, 48035312, 48110622, 48414617, 49699376, 50059584, 50104955, 50122971, 50122972, 57322878, 77058650, 81041248, 85213182, 85787105
|
||||
| SuperDrug ATC ID |
C02CA06
|
||||
| SuperDrug CAS ID |
cas=034661751
|
||||
| Target and Pathway | |||||
| Target(s) | Alpha-1 adrenergic receptor | Target Info | Antagonist | [2] | |
| 5-hydroxytryptamine 1A receptor | Target Info | Agonist | [2] | ||
| KEGG Pathway | cAMP signaling pathway | ||||
| Neuroactive ligand-receptor interaction | |||||
| Serotonergic synapse | |||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathway | |||||
| Reactome | Serotonin receptors | ||||
| G alpha (i) signalling events | |||||
| WikiPathways | Serotonin HTR1 Group and FOS Pathway | ||||
| SIDS Susceptibility Pathways | |||||
| Monoamine GPCRs | |||||
| GPCRs, Class A Rhodopsin-like | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| References | |||||
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | ||||
| REF 2 | Urapidil. A reappraisal of its use in the management of hypertension. Drugs. 1998 Nov;56(5):929-55. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.